Inventor · Ludwigshafen, DE

Mario Mezler

24Patents
5h-index
41Co-inventors
65Inventor score

Filing activity: Nov 17, 2000 → Aug 26, 2016

Most-cited inventions

PatentTitleAreaCited byStatus
US8642587B2 Heterocyclic compounds, pharmaceutical compositions containing them, and their use in therapy Chemistry; Metallurgy 60 Active
US8420670B2 4-benzylaminoquinolines, pharmaceutical compositions containing them, and their use in therapy Chemistry; Metallurgy 17 Active
US8653100B2 Tetrahydroisoquinolines, pharmaceutical compositions containing them, and their use in therapy Chemistry; Metallurgy 17 Active
US8563617B2 Aminotetraline derivatives, pharmaceutical compositions containing them, and their use in therapy Chemistry; Metallurgy 12 Active
US8440694B2 Quinoline compounds suitable for treating disorders that respond to modulation of the serotonin-5-HT6 receptor Chemistry; Metallurgy 12 Active
US8664214B2 Small molecule potentiators of metabotropic glutamate receptors I Chemistry; Metallurgy 5 Active
US7790727B2 Benzenesulfonanilide compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptor Chemistry; Metallurgy 2 Active
US9242933B2 Heterocyclic compounds as positive modulators of metabotropic glutamate receptor 2 (mGlu2 receptor) Chemistry; Metallurgy 2 Active
US8507469B2 Azetidin compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptor Chemistry; Metallurgy 2 Active
US8957089B2 Tetrahydroisoquinolines, pharmaceutical compositions containing them, and their use in therapy Chemistry; Metallurgy 1 Active
US8242102B2 Quinoline compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptor Chemistry; Metallurgy 1 Active
US9067871B2 Aminotetraline derivatives, pharmaceutical compositions containing them, and their use in therapy Chemistry; Metallurgy 0 Active
US8314120B2 Small molecule potentiators of metabotropic glutamate receptors Chemistry; Metallurgy 0 Active
US9096619B2 Aminotetraline derivatives, pharmaceutical compositions containing them, and their use in therapy Chemistry; Metallurgy 0 Active
US9309200B2 Benzazepine derivatives, pharmaceutical compositions containing them, and their use in therapy Chemistry; Metallurgy 0 Active
US6794149B1 GABA B receptors Human Necessities 0 Expired
US9255146B2 Neutralizing monoclonal antibodies against the Nogo-66 receptor (NgR) and uses thereof Emerging Cross-Sectional Technologies 0 Active
US8877794B2 Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy Chemistry; Metallurgy 0 Active
US7906120B2 Neutralizing monoclonal antibodies against the Nogo-66 receptor (NgR) Emerging Cross-Sectional Technologies 0 Active
US9045459B2 Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy Chemistry; Metallurgy 0 Active
US9238619B2 Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy Chemistry; Metallurgy 0 Active
US10556907B2 Fused heterocyclic compounds as S1P modulators Chemistry; Metallurgy 0 Active
US10040852B2 Neutralizing monoclonal antibodies against the Nogo-66 receptor (NgR) and uses thereof Emerging Cross-Sectional Technologies 0 Active
US8293913B2 Quinoline compounds suitable for treating disorders that respond to modulation of the serotonin-5-HT6 receptor Chemistry; Metallurgy 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.